whitepaper
Whitepaper: The impacts of Brexit on the bio/pharmaceutical industry
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
List view / Grid view
cGMP
product
Paul DiMarco introduces BioSpectra as your provider of critical small molecule excipients and APIs
BioSpectra offers US based, custom GMP manufacturing of small molecules...
news
FDA steps up action to ensure quality of compound drugs
The FDA is seeking closer collaboration with state authorities to ensure the quality of compounded drugs and the public’s access to them...
news
Russian Institute for Drugs and Good Practices unveils new data guide
Improving data integrity is the aim of a new guide published by the Russian State Institute for Drugs and Good Practices in collaboration with consultancy PQE Group...
article
Scientific Poster & Whitepaper Gallery 2018
This supplement brings together leading companies with compelling science stories to share in a simple-to-understand format.
whitepaper
Whitepaper: Meeting modern data integrity and compliance requirements
FDA was perhaps understating a point when it said in its April 2016 Draft Guidance: Data Integrity and Compliance with cGMP that the increasing number of data integrity-related cGMP violations identified during its inspections was ‘troubling’...
article
Guide to Outsourcing
Welcome to European Pharmaceutical Review’s Guide to Outsourcing, the fourth in our series of ‘Guide to…’ supplements. In this edition, five leading companies that provide outsourcing services explain how their portfolio meets current industry needs.
whitepaper
Application Note: Method suitability in microbiology: understanding complex cGMP guidelines
Particularly in the pharmaceutical industry, microbiological method development and, specifically, method suitability is often overlooked or left until the end of a project. However, it is important to give both method suitability and development due consideration as it can be a complicated process involving wide specifications, vague parameters and the…
webinar
Bio-Contamination, Risk Profiling and Proactive Response
29 May 2014 | By TSI Inc.
This pharma webinar provides an overview of the new PHSS Bio-contamination Monograph and the value of real-time airborne viable particle detection in GMP classified areas.
webinar
Detection, quantification and visualisation of protein interactions for hit profiling by high content screening
3 February 2014 | By Sigma-Aldrich
This pharma webinar provides an overview of how compound profiling using the PLA® (Proximity Ligation Assay) technology can be used for in situ analysis of protein interactions by high content screening as part of the hit-to-lead workflow, the key advantage being the ability to provide evidence for target engagement of…
webinar
Navigating the Complexities of Pharmaceutical Manufacturing Regulations
8 January 2014 | By Rigaku Raman Technologies
This pharma webinar will introduce unconventional approaches to enhance quality programs with the use of modern handheld technology.
webinar
Handheld Raman – Cut costs, improve efficiency & move toward 100% testing
18 September 2012 | By B&W Tek
In this free one hour instructional webinar you will learn how handheld Raman reduces costs and improves efficiency, the move to mandatory 100% testing of incoming raw materials, and recent developments in handheld Raman technology...
